New York, Dec. 15, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Medical Exoskeleton Industry" - https://www.reportlinker.com/p06032149/?utm_source=GNW
7 Billion by 2027, growing at aCAGR of 34.8% over the period 2020-2027. Hardware, one of the segments analyzed in the report, is projected to record 35.4% CAGR and reach US$1.1 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Software segment is readjusted to a revised 33.8% CAGR for the next 7-year period.
- The U.S. Market is Estimated at $64.5 Million, While China is Forecast to Grow at 33.7% CAGR
- The Medical Exoskeleton market in the U.S. is estimated at US$64.5 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$291.9 Million by the year 2027 trailing a CAGR of 33.7% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 31.5% and 29.8% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 24.4% CAGR.
- Select Competitors (Total 34 Featured) -
- Bionik Laboratories Corp
- B-TEMIA Inc.
- Cyberdyne Inc.
- Ekso Bionics Holdings, Inc.
- ExoAtlet
- Gogoa Mobility Robots SL
- Hocoma AG (A Subsidiary of DIH Technologies)
- Parker Hannifin Corp
- ReWalk Robotics Ltd
- Rex Bionics Ltd.
- Tyromotion GmbH
- US Bionics
- Wearable Robotics SRL
Read the full report: https://www.reportlinker.com/p06032149/?utm_source=GNW
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Medical
Exoskeleton by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ for Years 2020 through 2027 and
% CAGR
Table 2: World Historic Review for Medical Exoskeleton by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
Table 3: World 15-Year Perspective for Medical Exoskeleton by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World Markets for Years 2012, 2020 & 2027
Table 4: World Current & Future Analysis for Hardware by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ for Years 2020 through 2027 and % CAGR
Table 5: World Historic Review for Hardware by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ for Years 2012 through 2019 and % CAGR
Table 6: World 15-Year Perspective for Hardware by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2012, 2020 & 2027
Table 7: World Current & Future Analysis for Software by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ for Years 2020 through 2027 and % CAGR
Table 8: World Historic Review for Software by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ for Years 2012 through 2019 and % CAGR
Table 9: World 15-Year Perspective for Software by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2012, 2020 & 2027
Table 10: World Current & Future Analysis for Powered by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ for Years 2020 through 2027 and % CAGR
Table 11: World Historic Review for Powered by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ for Years 2012 through 2019 and % CAGR
Table 12: World 15-Year Perspective for Powered by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2012, 2020 & 2027
Table 13: World Current & Future Analysis for Passive by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ for Years 2020 through 2027 and % CAGR
Table 14: World Historic Review for Passive by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ for Years 2012 through 2019 and % CAGR
Table 15: World 15-Year Perspective for Passive by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2012, 2020 & 2027
Table 16: World Current & Future Analysis for Mobile by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ for Years 2020 through 2027 and % CAGR
Table 17: World Historic Review for Mobile by Geographic Region -
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World Markets - Independent Analysis of Annual Sales in US$ for
Years 2012 through 2019 and % CAGR
Table 18: World 15-Year Perspective for Mobile by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2012, 2020 & 2027
Table 19: World Current & Future Analysis for Stationary by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ for Years 2020 through 2027 and % CAGR
Table 20: World Historic Review for Stationary by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ for Years 2012 through 2019 and % CAGR
Table 21: World 15-Year Perspective for Stationary by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027
III. MARKET ANALYSIS
UNITED STATES
Table 22: USA Current & Future Analysis for Medical Exoskeleton
by Component - Hardware and Software - Independent Analysis of
Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
Table 23: USA Historic Review for Medical Exoskeleton by
Component - Hardware and Software Markets - Independent
Analysis of Annual Sales in US$ for Years 2012 through 2019 and
% CAGR
Table 24: USA 15-Year Perspective for Medical Exoskeleton by
Component - Percentage Breakdown of Value Sales for Hardware
and Software for the Years 2012, 2020 & 2027
Table 25: USA Current & Future Analysis for Medical Exoskeleton
by Type - Powered and Passive - Independent Analysis of Annual
Sales in US$ for the Years 2020 through 2027 and % CAGR
Table 26: USA Historic Review for Medical Exoskeleton by Type -
Powered and Passive Markets - Independent Analysis of Annual
Sales in US$ for Years 2012 through 2019 and % CAGR
Table 27: USA 15-Year Perspective for Medical Exoskeleton by
Type - Percentage Breakdown of Value Sales for Powered and
Passive for the Years 2012, 2020 & 2027
Table 28: USA Current & Future Analysis for Medical Exoskeleton
by Mobility - Mobile and Stationary - Independent Analysis of
Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
Table 29: USA Historic Review for Medical Exoskeleton by
Mobility - Mobile and Stationary Markets - Independent Analysis
of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
Table 30: USA 15-Year Perspective for Medical Exoskeleton by
Mobility - Percentage Breakdown of Value Sales for Mobile and
Stationary for the Years 2012, 2020 & 2027
CANADA
Table 31: Canada Current & Future Analysis for Medical
Exoskeleton by Component - Hardware and Software - Independent
Analysis of Annual Sales in US$ for the Years 2020 through 2027
and % CAGR
Table 32: Canada Historic Review for Medical Exoskeleton by
Component - Hardware and Software Markets - Independent
Analysis of Annual Sales in US$ for Years 2012 through 2019 and
% CAGR
Table 33: Canada 15-Year Perspective for Medical Exoskeleton by
Component - Percentage Breakdown of Value Sales for Hardware
and Software for the Years 2012, 2020 & 2027
Table 34: Canada Current & Future Analysis for Medical
Exoskeleton by Type - Powered and Passive - Independent
Analysis of Annual Sales in US$ for the Years 2020 through 2027
and % CAGR
Table 35: Canada Historic Review for Medical Exoskeleton by
Type - Powered and Passive Markets - Independent Analysis of
Annual Sales in US$ for Years 2012 through 2019 and % CAGR
Table 36: Canada 15-Year Perspective for Medical Exoskeleton by
Type - Percentage Breakdown of Value Sales for Powered and
Passive for the Years 2012, 2020 & 2027
Table 37: Canada Current & Future Analysis for Medical
Exoskeleton by Mobility - Mobile and Stationary - Independent
Analysis of Annual Sales in US$ for the Years 2020 through 2027
and % CAGR
Table 38: Canada Historic Review for Medical Exoskeleton by
Mobility - Mobile and Stationary Markets - Independent Analysis
of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
Table 39: Canada 15-Year Perspective for Medical Exoskeleton by
Mobility - Percentage Breakdown of Value Sales for Mobile and
Stationary for the Years 2012, 2020 & 2027
JAPAN
Table 40: Japan Current & Future Analysis for Medical
Exoskeleton by Component - Hardware and Software - Independent
Analysis of Annual Sales in US$ for the Years 2020 through 2027
and % CAGR
Table 41: Japan Historic Review for Medical Exoskeleton by
Component - Hardware and Software Markets - Independent
Analysis of Annual Sales in US$ for Years 2012 through 2019 and
% CAGR
Table 42: Japan 15-Year Perspective for Medical Exoskeleton by
Component - Percentage Breakdown of Value Sales for Hardware
and Software for the Years 2012, 2020 & 2027
Table 43: Japan Current & Future Analysis for Medical
Exoskeleton by Type - Powered and Passive - Independent
Analysis of Annual Sales in US$ for the Years 2020 through 2027
and % CAGR
Table 44: Japan Historic Review for Medical Exoskeleton by Type -
Powered and Passive Markets - Independent Analysis of Annual
Sales in US$ for Years 2012 through 2019 and % CAGR
Table 45: Japan 15-Year Perspective for Medical Exoskeleton by
Type - Percentage Breakdown of Value Sales for Powered and
Passive for the Years 2012, 2020 & 2027
Table 46: Japan Current & Future Analysis for Medical
Exoskeleton by Mobility - Mobile and Stationary - Independent
Analysis of Annual Sales in US$ for the Years 2020 through 2027
and % CAGR
Table 47: Japan Historic Review for Medical Exoskeleton by
Mobility - Mobile and Stationary Markets - Independent Analysis
of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
Table 48: Japan 15-Year Perspective for Medical Exoskeleton by
Mobility - Percentage Breakdown of Value Sales for Mobile and
Stationary for the Years 2012, 2020 & 2027
CHINA
Table 49: China Current & Future Analysis for Medical
Exoskeleton by Component - Hardware and Software - Independent
Analysis of Annual Sales in US$ for the Years 2020 through 2027
and % CAGR
Table 50: China Historic Review for Medical Exoskeleton by
Component - Hardware and Software Markets - Independent
Analysis of Annual Sales in US$ for Years 2012 through 2019 and
% CAGR
Table 51: China 15-Year Perspective for Medical Exoskeleton by
Component - Percentage Breakdown of Value Sales for Hardware
and Software for the Years 2012, 2020 & 2027
Table 52: China Current & Future Analysis for Medical
Exoskeleton by Type - Powered and Passive - Independent
Analysis of Annual Sales in US$ for the Years 2020 through 2027
and % CAGR
Table 53: China Historic Review for Medical Exoskeleton by Type -
Powered and Passive Markets - Independent Analysis of Annual
Sales in US$ for Years 2012 through 2019 and % CAGR
Table 54: China 15-Year Perspective for Medical Exoskeleton by
Type - Percentage Breakdown of Value Sales for Powered and
Passive for the Years 2012, 2020 & 2027
Table 55: China Current & Future Analysis for Medical
Exoskeleton by Mobility - Mobile and Stationary - Independent
Analysis of Annual Sales in US$ for the Years 2020 through 2027
and % CAGR
Table 56: China Historic Review for Medical Exoskeleton by
Mobility - Mobile and Stationary Markets - Independent Analysis
of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
Table 57: China 15-Year Perspective for Medical Exoskeleton by
Mobility - Percentage Breakdown of Value Sales for Mobile and
Stationary for the Years 2012, 2020 & 2027
EUROPE
Table 58: Europe Current & Future Analysis for Medical
Exoskeleton by Geographic Region - France, Germany, Italy, UK
and Rest of Europe Markets - Independent Analysis of Annual
Sales in US$ for Years 2020 through 2027 and % CAGR
Table 59: Europe Historic Review for Medical Exoskeleton by
Geographic Region - France, Germany, Italy, UK and Rest of
Europe Markets - Independent Analysis of Annual Sales in US$
for Years 2012 through 2019 and % CAGR
Table 60: Europe 15-Year Perspective for Medical Exoskeleton by
Geographic Region - Percentage Breakdown of Value Sales for
France, Germany, Italy, UK and Rest of Europe Markets for Years
2012, 2020 & 2027
Table 61: Europe Current & Future Analysis for Medical
Exoskeleton by Component - Hardware and Software - Independent
Analysis of Annual Sales in US$ for the Years 2020 through 2027
and % CAGR
Table 62: Europe Historic Review for Medical Exoskeleton by
Component - Hardware and Software Markets - Independent
Analysis of Annual Sales in US$ for Years 2012 through 2019 and
% CAGR
Table 63: Europe 15-Year Perspective for Medical Exoskeleton by
Component - Percentage Breakdown of Value Sales for Hardware
and Software for the Years 2012, 2020 & 2027
Table 64: Europe Current & Future Analysis for Medical
Exoskeleton by Type - Powered and Passive - Independent
Analysis of Annual Sales in US$ for the Years 2020 through 2027
and % CAGR
Table 65: Europe Historic Review for Medical Exoskeleton by
Type - Powered and Passive Markets - Independent Analysis of
Annual Sales in US$ for Years 2012 through 2019 and % CAGR
Table 66: Europe 15-Year Perspective for Medical Exoskeleton by
Type - Percentage Breakdown of Value Sales for Powered and
Passive for the Years 2012, 2020 & 2027
Table 67: Europe Current & Future Analysis for Medical
Exoskeleton by Mobility - Mobile and Stationary - Independent
Analysis of Annual Sales in US$ for the Years 2020 through 2027
and % CAGR
Table 68: Europe Historic Review for Medical Exoskeleton by
Mobility - Mobile and Stationary Markets - Independent Analysis
of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
Table 69: Europe 15-Year Perspective for Medical Exoskeleton by
Mobility - Percentage Breakdown of Value Sales for Mobile and
Stationary for the Years 2012, 2020 & 2027
FRANCE
Table 70: France Current & Future Analysis for Medical
Exoskeleton by Component - Hardware and Software - Independent
Analysis of Annual Sales in US$ for the Years 2020 through 2027
and % CAGR
Table 71: France Historic Review for Medical Exoskeleton by
Component - Hardware and Software Markets - Independent
Analysis of Annual Sales in US$ for Years 2012 through 2019 and
% CAGR
Table 72: France 15-Year Perspective for Medical Exoskeleton by
Component - Percentage Breakdown of Value Sales for Hardware
and Software for the Years 2012, 2020 & 2027
Table 73: France Current & Future Analysis for Medical
Exoskeleton by Type - Powered and Passive - Independent
Analysis of Annual Sales in US$ for the Years 2020 through 2027
and % CAGR
Table 74: France Historic Review for Medical Exoskeleton by
Type - Powered and Passive Markets - Independent Analysis of
Annual Sales in US$ for Years 2012 through 2019 and % CAGR
Table 75: France 15-Year Perspective for Medical Exoskeleton by
Type - Percentage Breakdown of Value Sales for Powered and
Passive for the Years 2012, 2020 & 2027
Table 76: France Current & Future Analysis for Medical
Exoskeleton by Mobility - Mobile and Stationary - Independent
Analysis of Annual Sales in US$ for the Years 2020 through 2027
and % CAGR
Table 77: France Historic Review for Medical Exoskeleton by
Mobility - Mobile and Stationary Markets - Independent Analysis
of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
Table 78: France 15-Year Perspective for Medical Exoskeleton by
Mobility - Percentage Breakdown of Value Sales for Mobile and
Stationary for the Years 2012, 2020 & 2027
GERMANY
Table 79: Germany Current & Future Analysis for Medical
Exoskeleton by Component - Hardware and Software - Independent
Analysis of Annual Sales in US$ for the Years 2020 through 2027
and % CAGR
Table 80: Germany Historic Review for Medical Exoskeleton by
Component - Hardware and Software Markets - Independent
Analysis of Annual Sales in US$ for Years 2012 through 2019 and
% CAGR
Table 81: Germany 15-Year Perspective for Medical Exoskeleton
by Component - Percentage Breakdown of Value Sales for Hardware
and Software for the Years 2012, 2020 & 2027
Table 82: Germany Current & Future Analysis for Medical
Exoskeleton by Type - Powered and Passive - Independent
Analysis of Annual Sales in US$ for the Years 2020 through 2027
and % CAGR
Table 83: Germany Historic Review for Medical Exoskeleton by
Type - Powered and Passive Markets - Independent Analysis of
Annual Sales in US$ for Years 2012 through 2019 and % CAGR
Table 84: Germany 15-Year Perspective for Medical Exoskeleton
by Type - Percentage Breakdown of Value Sales for Powered and
Passive for the Years 2012, 2020 & 2027
Table 85: Germany Current & Future Analysis for Medical
Exoskeleton by Mobility - Mobile and Stationary - Independent
Analysis of Annual Sales in US$ for the Years 2020 through 2027
and % CAGR
Table 86: Germany Historic Review for Medical Exoskeleton by
Mobility - Mobile and Stationary Markets - Independent Analysis
of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
Table 87: Germany 15-Year Perspective for Medical Exoskeleton
by Mobility - Percentage Breakdown of Value Sales for Mobile
and Stationary for the Years 2012, 2020 & 2027
ITALY
Table 88: Italy Current & Future Analysis for Medical
Exoskeleton by Component - Hardware and Software - Independent
Analysis of Annual Sales in US$ for the Years 2020 through 2027
and % CAGR
Table 89: Italy Historic Review for Medical Exoskeleton by
Component - Hardware and Software Markets - Independent
Analysis of Annual Sales in US$ for Years 2012 through 2019 and
% CAGR
Table 90: Italy 15-Year Perspective for Medical Exoskeleton by
Component - Percentage Breakdown of Value Sales for Hardware
and Software for the Years 2012, 2020 & 2027
Table 91: Italy Current & Future Analysis for Medical
Exoskeleton by Type - Powered and Passive - Independent
Analysis of Annual Sales in US$ for the Years 2020 through 2027
and % CAGR
Table 92: Italy Historic Review for Medical Exoskeleton by Type -
Powered and Passive Markets - Independent Analysis of Annual
Sales in US$ for Years 2012 through 2019 and % CAGR
Table 93: Italy 15-Year Perspective for Medical Exoskeleton by
Type - Percentage Breakdown of Value Sales for Powered and
Passive for the Years 2012, 2020 & 2027
Table 94: Italy Current & Future Analysis for Medical
Exoskeleton by Mobility - Mobile and Stationary - Independent
Analysis of Annual Sales in US$ for the Years 2020 through 2027
and % CAGR
Table 95: Italy Historic Review for Medical Exoskeleton by
Mobility - Mobile and Stationary Markets - Independent Analysis
of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
Table 96: Italy 15-Year Perspective for Medical Exoskeleton by
Mobility - Percentage Breakdown of Value Sales for Mobile and
Stationary for the Years 2012, 2020 & 2027
UNITED KINGDOM
Table 97: UK Current & Future Analysis for Medical Exoskeleton
by Component - Hardware and Software - Independent Analysis of
Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
Table 98: UK Historic Review for Medical Exoskeleton by
Component - Hardware and Software Markets - Independent
Analysis of Annual Sales in US$ for Years 2012 through 2019 and
% CAGR
Table 99: UK 15-Year Perspective for Medical Exoskeleton by
Component - Percentage Breakdown of Value Sales for Hardware
and Software for the Years 2012, 2020 & 2027
Table 100: UK Current & Future Analysis for Medical Exoskeleton
by Type - Powered and Passive - Independent Analysis of Annual
Sales in US$ for the Years 2020 through 2027 and % CAGR
Table 101: UK Historic Review for Medical Exoskeleton by Type -
Powered and Passive Markets - Independent Analysis of Annual
Sales in US$ for Years 2012 through 2019 and % CAGR
Table 102: UK 15-Year Perspective for Medical Exoskeleton by
Type - Percentage Breakdown of Value Sales for Powered and
Passive for the Years 2012, 2020 & 2027
Table 103: UK Current & Future Analysis for Medical Exoskeleton
by Mobility - Mobile and Stationary - Independent Analysis of
Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
Table 104: UK Historic Review for Medical Exoskeleton by
Mobility - Mobile and Stationary Markets - Independent Analysis
of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
Table 105: UK 15-Year Perspective for Medical Exoskeleton by
Mobility - Percentage Breakdown of Value Sales for Mobile and
Stationary for the Years 2012, 2020 & 2027
REST OF EUROPE
Table 106: Rest of Europe Current & Future Analysis for Medical
Exoskeleton by Component - Hardware and Software - Independent
Analysis of Annual Sales in US$ for the Years 2020 through 2027
and % CAGR
Table 107: Rest of Europe Historic Review for Medical
Exoskeleton by Component - Hardware and Software Markets -
Independent Analysis of Annual Sales in US$ for Years 2012
through 2019 and % CAGR
Table 108: Rest of Europe 15-Year Perspective for Medical
Exoskeleton by Component - Percentage Breakdown of Value Sales
for Hardware and Software for the Years 2012, 2020 & 2027
Table 109: Rest of Europe Current & Future Analysis for Medical
Exoskeleton by Type - Powered and Passive - Independent
Analysis of Annual Sales in US$ for the Years 2020 through 2027
and % CAGR
Table 110: Rest of Europe Historic Review for Medical
Exoskeleton by Type - Powered and Passive Markets - Independent
Analysis of Annual Sales in US$ for Years 2012 through 2019 and
% CAGR
Table 111: Rest of Europe 15-Year Perspective for Medical
Exoskeleton by Type - Percentage Breakdown of Value Sales for
Powered and Passive for the Years 2012, 2020 & 2027
Table 112: Rest of Europe Current & Future Analysis for Medical
Exoskeleton by Mobility - Mobile and Stationary - Independent
Analysis of Annual Sales in US$ for the Years 2020 through 2027
and % CAGR
Table 113: Rest of Europe Historic Review for Medical
Exoskeleton by Mobility - Mobile and Stationary Markets -
Independent Analysis of Annual Sales in US$ for Years 2012
through 2019 and % CAGR
Table 114: Rest of Europe 15-Year Perspective for Medical
Exoskeleton by Mobility - Percentage Breakdown of Value Sales
for Mobile and Stationary for the Years 2012, 2020 & 2027
ASIA-PACIFIC
Table 115: Asia-Pacific Current & Future Analysis for Medical
Exoskeleton by Component - Hardware and Software - Independent
Analysis of Annual Sales in US$ for the Years 2020 through 2027
and % CAGR
Table 116: Asia-Pacific Historic Review for Medical Exoskeleton
by Component - Hardware and Software Markets - Independent
Analysis of Annual Sales in US$ for Years 2012 through 2019 and
% CAGR
Table 117: Asia-Pacific 15-Year Perspective for Medical
Exoskeleton by Component - Percentage Breakdown of Value Sales
for Hardware and Software for the Years 2012, 2020 & 2027
Table 118: Asia-Pacific Current & Future Analysis for Medical
Exoskeleton by Type - Powered and Passive - Independent
Analysis of Annual Sales in US$ for the Years 2020 through 2027
and % CAGR
Table 119: Asia-Pacific Historic Review for Medical Exoskeleton
by Type - Powered and Passive Markets - Independent Analysis of
Annual Sales in US$ for Years 2012 through 2019 and % CAGR
Table 120: Asia-Pacific 15-Year Perspective for Medical
Exoskeleton by Type - Percentage Breakdown of Value Sales for
Powered and Passive for the Years 2012, 2020 & 2027
Table 121: Asia-Pacific Current & Future Analysis for Medical
Exoskeleton by Mobility - Mobile and Stationary - Independent
Analysis of Annual Sales in US$ for the Years 2020 through 2027
and % CAGR
Table 122: Asia-Pacific Historic Review for Medical Exoskeleton
by Mobility - Mobile and Stationary Markets - Independent
Analysis of Annual Sales in US$ for Years 2012 through 2019 and
% CAGR
Table 123: Asia-Pacific 15-Year Perspective for Medical
Exoskeleton by Mobility - Percentage Breakdown of Value Sales
for Mobile and Stationary for the Years 2012, 2020 & 2027
REST OF WORLD
Table 124: Rest of World Current & Future Analysis for Medical
Exoskeleton by Component - Hardware and Software - Independent
Analysis of Annual Sales in US$ for the Years 2020 through 2027
and % CAGR
Table 125: Rest of World Historic Review for Medical
Exoskeleton by Component - Hardware and Software Markets -
Independent Analysis of Annual Sales in US$ for Years 2012
through 2019 and % CAGR
Table 126: Rest of World 15-Year Perspective for Medical
Exoskeleton by Component - Percentage Breakdown of Value Sales
for Hardware and Software for the Years 2012, 2020 & 2027
Table 127: Rest of World Current & Future Analysis for Medical
Exoskeleton by Type - Powered and Passive - Independent
Analysis of Annual Sales in US$ for the Years 2020 through 2027
and % CAGR
Table 128: Rest of World Historic Review for Medical
Exoskeleton by Type - Powered and Passive Markets - Independent
Analysis of Annual Sales in US$ for Years 2012 through 2019 and
% CAGR
Table 129: Rest of World 15-Year Perspective for Medical
Exoskeleton by Type - Percentage Breakdown of Value Sales for
Powered and Passive for the Years 2012, 2020 & 2027
Table 130: Rest of World Current & Future Analysis for Medical
Exoskeleton by Mobility - Mobile and Stationary - Independent
Analysis of Annual Sales in US$ for the Years 2020 through 2027
and % CAGR
Table 131: Rest of World Historic Review for Medical
Exoskeleton by Mobility - Mobile and Stationary Markets -
Independent Analysis of Annual Sales in US$ for Years 2012
through 2019 and % CAGR
Table 132: Rest of World 15-Year Perspective for Medical
Exoskeleton by Mobility - Percentage Breakdown of Value Sales
for Mobile and Stationary for the Years 2012, 2020 & 2027
IV. COMPETITION
Total Companies Profiled: 34
Read the full report: https://www.reportlinker.com/p06032149/?utm_source=GNW
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
__________________________